News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Hepatitis C

Latest News

March 7th 2012

More Patients Relapse in Gilead Hepatitis C Trial

February 22nd 2012

Teva Is Said to Pay $250 Million to End Nevada Colonoscopy Hepatitis Cases

February 10th 2012

FDA: HCV Drug Interferes With HIV Meds

January 12th 2012

Dr. David Winston Urges Physicians To Routinely Screen for Hepatitis C

January 6th 2012

Novel Hepatitis C Vaccine Induces T Cell Responses

CME Content

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Recap: The 53rd American Society of Hematology Annual Meeting and Exposition

By

December 19th 2011

Hepatitis C Birth Cohort Screening is Cost-Effective

By

November 7th 2011

Absenteeism and Productivity Among Employees Being Treated for Hepatitis C

ByRichard A. Brook, MS, MBA,Nathan L. Kleinman, PhD,Jun Su, MD, MSc,Patricia K. Corey-Lisle, PhD,Uchenna H. Iloeje, MD, MPH

October 10th 2011

Employees with hepatitis C (HCV) who underwent existing treatments had more absences and higher indirect costs than HCVinfected employees who did not undergo treatment.

HCV Screening Practices and Prevalence in an MCO, 2000-2007

ByDouglas W. Roblin, PhD,Bryce D. Smith, PhD,Cindy M. Weinbaum, MD, MPH,Miriam E. Sabin, PhD

August 5th 2011

HCV screening and prevalence estimates, unadjusted and adjusted for HCV risk factors, are examined in this 8-year observational study of a managed care organization.

Case 2: Emerging Therapeutic Options in Hepatitis C Virus Infection (CE)

Byby Fred Poordad, MD,Vandana Khungar, MD, MSc

April 26th 2011

Trending on AJMC

Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access

Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma

Congress Unveils Massive Funding Bill to Avert Shutdown

Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD

Balancing Innovation With Administrative Burdens in Cancer Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.